🇺🇸 FDA
Patent

US 6150508

Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

expired A61KA61K38/00A61P

Quick answer

US patent 6150508 (Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen) held by Northwest Biotherapeutics, Inc. expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Northwest Biotherapeutics, Inc.
Grant date
Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P13/08, A61P35/00